Phenotype analysis and efficacy of irbesartan in Col4a5 R471X mice harboring a mutation similar to an Alport syndrome patient

Kentarou Hashikami; Mitsuharu Matsumoto; Manami Kaneko; Michiyasu Takeyama

[1P-0558] Phenotype analysis and efficacy of irbesartan in Col4a5 R471X mice harboring a mutation similar to an Alport syndrome patient

〇Kentarou Hashikami¹, Mitsuharu Matsumoto¹, Manami Kaneko¹, Michiyasu Takeyama¹ (1.INB., Axcelead Drug Discovery Partners, Inc.)

Alport, CRISPR/Cas9, Col4a5, CKD

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 42nd Annual Meeting of the Molecular Biology Society of Japan

[1P-0558] Phenotype analysis and efficacy of irbesartan in Col4a5 R471X mice harboring a mutation similar to an Alport syndrome patient

Password